A rapid reproducible test for determining rabies neutralizing antibody
about
Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st centuryKinetics of maternal immunity against rabies in fox cubs (Vulpes vulpes).Field trial with oral vaccination of dogs against rabies in the PhilippinesModification of immune function through exposure to dietary aflatoxin in Gambian childrenContact with domestic dogs increases pathogen exposure in endangered African wild dogs (Lycaon pictus)Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.Rabies-specific antibodies: measuring surrogates of protection against a fatal disease.The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination.More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniquesInterleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas.Importance of antirabies revaccination for an adequate antirabies protection in bovine newborns.Human lymphocyte proliferation responses following primary immunization with rabies vaccine as neoantigen.Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infectionProlonging morbidity in rabid dogs by intrathecal injection of attenuated rabies vaccine.Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.Bufotenine is able to block rabies virus infection in BHK-21 cellsUse of the hemadsorption phenomenon for determining virus and neutralizing antibody titers of rabies.Rabies virus glycoprotein. II. Biological and serological characterization.Pre-exposure immunization against rabies: a re-emphasis for veterinarians.A novel double-antigen sandwich enzyme-linked immunosorbent assay for Measurement of Antibodies against rabies virus.Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and catsImmunogenicity studies in carnivores using a rabies virus construct with a site-directed deletion in the phosphoprotein.A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogsLeptin, malnutrition, and immune response in rural Gambian children.Rabies vaccine preserved by vaporization is thermostable and immunogenicPost-exposure prophylaxis of murine rabies with polyinosinic-polycytidylic acid and chlorite-oxidized amyloseCross-protection of mice against a global spectrum of rabies virus variants.Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG.Characteristics and viral propagation properties of a new human diploid cell line, Walvax-2, and its suitability as a candidate cell substrate for vaccine production.Evaluation of ELISA for the detection of rabies virus antibodies from the thoracic liquid and muscle extract samples in the monitoring of fox oral vaccination campaigns.An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccinesValidation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples.Kinetics of rabies antibodies as a strategy for canine active immunization.Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccinesSufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats.Inadequate antibody response to rabies vaccine in immunocompromised patient.Synergic effects between ocellatin-F1 and bufotenine on the inhibition of BHK-21 cellular infection by the rabies virus
P2860
Q21092294-E582C73B-B802-4002-BB5E-57541B7AAB94Q24795787-F614AB11-4454-42B9-AC47-7DA824504D6AQ24796600-A0588856-8787-4698-9033-8C053FCCF26FQ24813565-15E55538-A61E-444C-8314-E479A0DF3281Q28740278-4017B627-3117-47E7-9E4D-7184E3224CBAQ33514828-2D23B7C4-CD5D-4A9F-94BE-288543346FE9Q33541002-5A1F677C-074C-415C-8DFC-2639A491BD58Q33620685-3B48EEA1-8E6A-4138-884D-363C3C0CB975Q33706236-51EF85B8-2305-4C23-B8F8-AE644C36388EQ33769901-76B06FE6-2AEE-4850-B178-C5F24D0C4C3DQ33867863-B57D4FB7-FF9E-40B0-8B5D-F7C7E3B76D4DQ33952864-A8FEB8D2-682B-466D-9B07-51FFFB3C770CQ33962720-29BD5E53-9049-4D01-9F5F-A5027803F1C2Q33999385-B3D6FD26-C8B3-4766-B1C2-635DB89973B4Q34055531-A8226CC8-8900-4555-8098-C551F35EE9D7Q34106638-B1AF2DB3-E67C-45FB-AB42-04E565137BC2Q34123393-DDB9D881-EC19-43F8-8FE0-77E209330249Q34334103-5879AB1F-4E9E-40DA-B348-B1172C31D3FDQ34374759-67EC2036-AA26-4EEB-B832-BE1FB698DCDAQ34395753-457B3D39-F009-4F9B-B3CE-7F94C2E6CBC2Q34408674-E78D8F1C-2C99-4C2F-BC94-C5EDECBD3A0CQ34504337-B4EA2265-536E-4F4F-B056-D4A5B4AB1A4AQ34975112-330EA30A-304A-4527-8557-635251E18FEDQ35140435-7C482AE5-920E-49CA-9382-3089C774344DQ35224835-068E7332-5F90-4B5E-A5BA-F45AD1AFFA82Q35232003-54186ABF-088E-4723-9B35-7FEDC1D24E31Q35273428-79A64FE9-5138-40CD-A086-F5E23C7447AEQ35434725-D6749721-F04B-49BB-A6A2-016139A46DF6Q35658335-5CC62A67-4356-4B03-A628-BC88A906FB88Q35845061-A61D0028-E56A-4B6B-913F-A11403B55E03Q35886459-F69CBBDA-5109-4F85-9C0D-A3ACE69E2068Q35919616-B1F2F36D-76D0-4BF2-BCF7-6E3314FCA19EQ36013617-53AB1669-86D1-4ECD-A3E7-99589AD9129EQ36057713-F81B60B1-A7EF-4797-B057-72464E45710DQ36086472-3B45B080-C57B-4A35-B376-9D7673DDB6EDQ36092787-EB2EBAB3-39B3-4DE8-89A4-1B360BC66363Q36168971-FB6EDF5A-7F6B-4675-808D-D645D4B00FE1Q36200661-EDE2E7D7-2B4A-4D0A-87AC-9CE56FC137A5Q36221220-33571C71-FBED-4710-9783-EB927B766952Q36344236-FA1CAD5B-0CF9-402E-8321-9978E7FCB166
P2860
A rapid reproducible test for determining rabies neutralizing antibody
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
A rapid reproducible test for determining rabies neutralizing antibody
@en
type
label
A rapid reproducible test for determining rabies neutralizing antibody
@en
prefLabel
A rapid reproducible test for determining rabies neutralizing antibody
@en
P2093
P2860
P921
P1476
A rapid reproducible test for determining rabies neutralizing antibody
@en
P2093
P2860
P304
P407
P577
1973-05-01T00:00:00Z